SCHEMBL12536765

SCHEMBL12536765

c1ccc(C2CCCNCCN2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 3/20 0.51
CHRNA4 P43681 3/20 0.51
CHRNA7 P36544 2/20 0.51
SLC18A3 Q16572 1/20 0.48
SIGMAR1 Q99720 1/20 0.48
MEN1 O00255 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
KMT2A Q03164 2/20 0.46
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2A6 P11509 1/20 0.46
CYP2C9 P11712 1/20 0.46
CHRM5 P08912 3/20 0.41
CHRM3 P20309 3/20 0.41
CHRM1 P11229 2/20 0.41
CHRM2 P08172 2/20 0.41
CHRM4 P08173 2/20 0.41
KDM1A O60341 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25997962 0.88 SLC18A3 (0.57) CHRNB2CHRNA4CHRNA7SLC18A3SIGMAR1
SCHEMBL6268948 0.88 SLC18A3 (0.57) CHRNB2CHRNA4CHRNA7SLC18A3SIGMAR1
SCHEMBL170704 0.88 CHRNB2 (0.63) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
SCHEMBL21232 0.88 CHRNB2 (0.63) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
SCHEMBL167264 0.88 CHRNB2 (0.63) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
Hydrochloric Acid SCHEMBL28196337 0.86 CHRNB2 (0.50) CHRNB2CHRNA4CHRNA7SLC18A3SIGMAR1
Hydrochloric Acid SCHEMBL12497423 0.86 CHRNB2 (0.61) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
Hydrochloric Acid SCHEMBL841177 0.86 CHRNB2 (0.61) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
Ammonia Solution, Strong SCHEMBL3517185 0.86 CHRNB2 (0.61) CHRNB2CHRNA4CHRNA7MEN1CYP2D6
Hydrochloric Acid SCHEMBL27952288 0.86 CHRNB2 (0.61) CHRNB2CHRNA4CHRNA7MEN1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110136814-A1 Diazepine and Diazocane Compounds As MC4 Agonists ANDREWS MARK DAVID 2011-06-09 US disclosed
US-20110136814-A1 Diazepine and Diazocane Compounds As MC4 Agonists ANDREWS MARK DAVID 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136814-A1 Diazepine and Diazocane Compounds As MC4 Agonists MC4R, CHRM4, GPR4 CHRNB2 77/4885CHRNA4 4/4885CHRNA7 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.